Key Takeaway: argenx to host conference call & webcast to report fourth quarter business update and full year 2018 financial results on February 28, 2019
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+42%
120-day peak, hindsight
Typical move
4%
average across 14 past catalysts
Lead asset
Empasiprubart
Phase 2 · Dermatomyositis
Full Press Release Details
argenx to host conference call & webcast to report fourth quarter business update and full year 2018 financial results on February 28, 2019.